Huateng Bio offers validated KOA models in rabbits via Modified Hulth and Collagenase methods. Features Lequesne scoring, MRI-based cartilage mapping, and OARSI-aligned histopathology.
Model Description
Knee osteoarthritis (KOA) is a disabling degenerative joint disease characterized by cartilage loss, subchondral bone remodeling, and synovial inflammation. With a 20.5% prevalence rate among adults ≥40 years in China, KOA imposes significant clinical burdens. Our rabbit models replicate human KOA progression through two validated methods:
Key Advantages:
✓ High reproducibility: 95% model success rate
✓ Clinical relevance: Mirrors human KOA pathology (OARSI Grade 3-4)
✓ Dual induction options: Acute vs chronic progression
Applications
• DMOAD (Disease-Modifying Osteoarthritis Drug) efficacy testing
• Cartilage repair biomaterial validation (hydrogels, scaffolds)
• Pain management strategy development
• Imaging technology optimization (MRI/PET tracer evaluation)
Modeling Protocols
1. Modified Hulth Method
Procedure:
Outcome:
2. Type II Collagenase Injection:
Intra-articular injection of 1.6 mg collagenase type II (dissolved in 50 μL saline)
Repeat injection at Day 3
Validation & Testing
Category |
Parameters |
Lequesne MG Score |
Gait analysis ∙ Joint swelling ∙ Pain-related behaviors |
Imaging Analysis |
• X-ray: Joint space narrowing ∙ Osteophyte scoring |
Histopathology |
|
Biochemical Profiling |
Serum COMP ∙ Synovial fluid IL-1β/TNF-α ∙ Urinary CTX-II |